Comprehensive review highlights impact of tobacco control measures

FHS
October 7, 2024
12:04 pm

Tobacco use remains a significant global health challenge, despite extensive control measures at both national and international levels.

Risk Adjusted Net Present Value: What is the current valuation of Aslan Pharmaceuticals’s Eblasakimab

The revenue for Eblasakimab is expected to reach an annual total of $430 mn by 2038 in the US based off GlobalDatas Expiry Model. The

September 8, 2024

Opinion | Fighting Back Against Acute Bacterial Meningitis

Claire Panosian Dunavan is a professor of medicine and infectious diseases at the David Geffen School of Medicine at UCLA and a past-president of the

January 21, 2024

Opinion | Value-Based Care: Filling Critical Gaps in Care and Clinician Leadership

David Nash is the Founding Dean Emeritus and Dr. Raymond C. and Doris N. Grandon Professor of Health Policy at the Jefferson College of Population

January 27, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.